We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cytrx Corp. (MM) | NASDAQ:CYTR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.31 | 0.30 | 0.3001 | 0 | 01:00:00 |
Delaware
|
|
000-15327
|
|
58-1642740
|
(State or other jurisdiction
of incorporation) |
|
(Commission File Number)
|
|
(IRS Employer
Identification No.) |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
(a)
|
On Thursday, August 9, 2018, CytRx Corporation (the "Company") held its 2018 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, 25,675,500 shares, or approximately 76.33% of all outstanding shares of common stock, were present either in person or by proxy.
|
(b)
|
CytRx stockholders voted on the matters set forth below, with the final vote results presented below.
|
Name
|
For
|
Withheld
|
Broker Non-Votes
|
Dr. Earl W. Brien
|
6,272,599
|
3,089,173
|
16,313,728
|
67.00%
|
33.00%
|
||
Mr. Joel K. Caldwell
|
6,225,532
|
3,135,128
|
16,313,728
|
66.51%
|
33.49%
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
4,760,214
|
4,523,967
|
77,591
|
16,313,728
|
50.85%
|
48.32%
|
0.83%
|
For
|
Against
|
Abstain
|
Broker Non-Votes*
|
17,449,279
|
7,190,630
|
1,035,591
|
0
|
67.96%
|
28.01%
|
4.03%
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
4,129,896
|
5,180,167
|
51,436
|
16,313,728
|
44.12%
|
55.88%
|
0.55%
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
4,454,335
|
4,859,085
|
48,352
|
16,313,728
|
47.58%
|
52.42%
|
0.52%
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
3,970,421
|
3,272,130
|
2,114,721
|
16,313,728
|
42.43%
|
57.57% **
|
22.60%
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
3,821,241
|
3,370,788
|
2,169,743
|
16,313,728
|
40.82%
|
59.18% **
|
23.18%
|
CYTRX CORPORATION | |||
Date: August 13, 2018
|
By:
|
/s/ JOHN Y. CALOZ | |
John Y. Caloz | |||
Chief Financial Officer | |||
1 Year Cytrx Chart |
1 Month Cytrx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions